Last reviewed · How we verify
NCT06803797
BCT Intervention For Walking Habit Among Caregivers of People With AD/ADRD
NA trial testing Behavior Change Technique Package in Inactivity, Physical in 100 participants. Participants enrolled and being followed up; not accepting new ones.
30 April 2026
Quick facts
| Lead sponsor | Northwell Health |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 100 |
| Start date | 18 March 2025 |
| Primary completion | 30 April 2026 |
| Estimated completion | 30 April 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Behavior Change Technique Package
Conditions studied
- Inactivity, Physical — all drugs for Inactivity, Physical →
Sponsor
Northwell Health — full company profile →
Who can join
Adults 18 to 85, any sex, with Inactivity, Physical. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This 12-week trial will test the efficacy of a multi-component, personalized text-message delivered behavior change technique (BCT) intervention to encourage habitual physical activity (defined as regular walking of 1,000 or more steps during a one-hour period on 7 consecutive days according to a personalized walking plan) among care providers of persons with AD/ADRD via the key mechanism of behavior change (MoBC) of automaticity. The main question it aims to answer whether a multi-component, personalized BCT intervention to increase a walking habit of 1,000 steps/day will lead to successful development of habitual walking among 60 percent of caregivers enrolled.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Protocol for a single-arm, multi-component behavior change technique (BCT) intervention to develop a walking habit among caregivers for persons with Alzheimer disease and related dementias (ADRD).
Miller D, Jordan L, Lambert S, Goodwin AM, et al · · 2026 · PMID 41621469 · DOI 10.1016/j.cct.2026.108248
Verify or expand the search:
- PubMed search for NCT06803797
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Behavior Change Technique Package
Trials testing the same drug.
- NCT06801912 — A BCT Intervention for an Hourly Activity Habit Among Caregivers for Persons With AD/ADRD · NA · active not recruiting
Other recruiting trials for Inactivity, Physical
Currently open trials in the same condition.
- NCT07429370 — The Effects of One Day of Activity on the Next Day's Exercise Response · NA · recruiting
- NCT07328568 — Effect of Low Volume Sprint Interval Training on Cardiorespiratory Fitness · NA · active not recruiting
- NCT06994104 — Exploring the Effects of Smartphone and Game Addiction on Activity, Sleep, Stress, and Pain in Youth · recruiting
- NCT06848335 — Improving Physical Activity Participation in Latinas With Mindfulness · NA · recruiting
- NCT06424847 — Effects of a Lifestyle and Sleep Intervention in Non-exercising Adults · NA · recruiting
Other Northwell Health trials
Trials by the same sponsor.
- NCT07253662 — Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients With Peritoneal Metastasis From Pancreatic Aden · Phase 1 · recruiting
- NCT07191041 — Emotional Urinary Tract Infection · not yet recruiting
- NCT07254091 — Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer · EARLY_PHASE1 · recruiting
- NCT07344961 — Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB) · recruiting
- NCT07193862 — Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Meta · EARLY_PHASE1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06803797 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northwell Health
- Last refreshed: 27 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06803797.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing